JP2024511953A5 - - Google Patents

Info

Publication number
JP2024511953A5
JP2024511953A5 JP2023555729A JP2023555729A JP2024511953A5 JP 2024511953 A5 JP2024511953 A5 JP 2024511953A5 JP 2023555729 A JP2023555729 A JP 2023555729A JP 2023555729 A JP2023555729 A JP 2023555729A JP 2024511953 A5 JP2024511953 A5 JP 2024511953A5
Authority
JP
Japan
Prior art keywords
spinosin
days
mammal
group
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023555729A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024511953A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/019870 external-priority patent/WO2022192618A1/en
Publication of JP2024511953A publication Critical patent/JP2024511953A/ja
Publication of JP2024511953A5 publication Critical patent/JP2024511953A5/ja
Pending legal-status Critical Current

Links

JP2023555729A 2021-03-11 2022-03-11 哺乳動物においてダニの侵入を防除するための餌および方法 Pending JP2024511953A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163159644P 2021-03-11 2021-03-11
US63/159,644 2021-03-11
PCT/US2022/019870 WO2022192618A1 (en) 2021-03-11 2022-03-11 Feed and methods for controlling tick infestations in a mammal

Publications (2)

Publication Number Publication Date
JP2024511953A JP2024511953A (ja) 2024-03-18
JP2024511953A5 true JP2024511953A5 (https=) 2025-03-06

Family

ID=83227122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023555729A Pending JP2024511953A (ja) 2021-03-11 2022-03-11 哺乳動物においてダニの侵入を防除するための餌および方法

Country Status (10)

Country Link
US (1) US20230413818A1 (https=)
EP (1) EP4304605A4 (https=)
JP (1) JP2024511953A (https=)
KR (1) KR20230161995A (https=)
CN (1) CN117377477A (https=)
AU (1) AU2022234318A1 (https=)
BR (1) BR112023017501A2 (https=)
CA (1) CA3211585A1 (https=)
MX (1) MX2023010379A (https=)
WO (1) WO2022192618A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122011100022I1 (de) * 1999-08-12 2011-10-20 Lilly Co Eli Verwendung von Spinosad oder einer Zusammensetzungenthaltend spinosad.
DE602004017347D1 (de) * 2003-11-04 2008-12-04 Intervet Int Bv Azol-pestiziden
UA108200C2 (uk) * 2009-05-08 2015-04-10 Лікарські форми та способи застосування ектопаразитоцидів
US20130210755A1 (en) * 2010-11-05 2013-08-15 Eli Lilly And Company Methods for inhibiting insect infestations
LT2811998T (lt) * 2012-02-06 2019-02-25 Merial, Inc. Paraziticidinės peroralinės veterinarinės kompozicijos, apimančios sistemiškai veikiančius aktyviuosius agentus, būdai ir jų panaudojimas
WO2014194503A1 (en) * 2013-06-06 2014-12-11 Eli Lilly And Company Parasiticidal compounds, methods, and formulations
US10736318B2 (en) * 2017-03-28 2020-08-11 Piedmont Animal Health Inc. Combinations of acaricides and insect growth regulators for control of fleas without emesis in animals

Similar Documents

Publication Publication Date Title
KR101653071B1 (ko) 선별적 s1p₁ 수용체 작동약에 대한 투약 섭생
US7462643B1 (en) Essential fatty acids in the prevention of cardiovascular events
CZ187097A3 (cs) Farmaceutický prostředek
JP2021527092A5 (https=)
TW200918044A (en) Anthelmintic combination
JP2011057714A (ja) 胃酸分泌阻害組成物
CN1124138A (zh) 用于治疗糖尿病并发症的组合物
JP2010515682A (ja) 喘息などの5−リポキシゲナーゼ活性上昇および/またはロイコトリエン活性上昇に関連する状態における使用のためのr−ジロートン
EP0796617A1 (fr) Utilisation de composés antiarythmiques dansla réduction de la mortalité post infarctus
JP2022554276A5 (https=)
AU2015358512B2 (en) Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same
SK280283B6 (sk) Farmaceutický prostriedok na liečenie žalúdočných
EP3554285A1 (en) Use of nad precursors for improving maternal health and/or offspring health
WO2005060955A1 (de) Pharmazeutische zusammensetzung aus einem beta-3-adrenozeptor-agonisten und einem in den prostaglandinstoffwechsel eingreifendem wirkstoff
CA2849213A1 (en) Combination of riluzole and ck-2017357 for treating als
JP2002504138A (ja) ロシグリタゾンおよびインスリンを用いる糖尿病の治療
JP2024511953A5 (https=)
CN113194924B (zh) 制备包含task-1和task-3通道抑制剂的药物剂型的方法及其在呼吸障碍治疗中的用途
JP2008540405A5 (https=)
JP2023542932A5 (https=)
KR20010015650A (ko) 조합 제제로서의 엔도텔린 길항제 및 베타-수용체 차단제
CA2684174C (fr) Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson
WO2004091615A1 (en) Combinations of paroxetine and 2-(r)-(4-fluoro-2-methyl-phenyl)-4-(s)-((8as)-6-oxo-hexahydro-pyrrolo[1,2-a]-pyrazin-2-yl)-piperidine-1-carboxylic acid[1-(r)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methylamide for treatment of depression/anxiety
JP2024524996A5 (https=)
EP0719552A2 (en) Pharmaceutical composition comprising a quinone derivative or a hydroquinone thereof for treating dermatitis